Immunologic response of mRNA SARS-CoV-2 vaccination in adolescent kidney transplant recipients청소년 신장 이식 환자에서 mRNA SARS-CoV-2 백신 접종의 면역학적 반응Article Published on 2022-02-012022-09-12 Journal: Pediatric Nephrology (Berlin, Germany) [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Adolescent age anti-S antibody antibody Antibody Response Cellular immune response Corticosteroid COVID-19 COVID-19 infection described dose ENhance evaluated Future General population Immunologic Immunosuppressed Immunosuppression inhibitor IQR kidney transplant kidney transplant recipient lower dose mRNA mRNA vaccine non-responders participant Patient patients pediatric positive positive antibody response Protein regimen reported routine clinical care Safe SARS-CoV-2 SARS-CoV-2 spike SARS-CoV-2 vaccination SARS-CoV-2 vaccine second dose solid organ transplant SOT SOT patient SOT patients Support the median the vaccine treated vaccination vaccine immunogenicity vaccine response Viremia [DOI] 10.1007/s00467-021-05256-9 PMC 바로가기 [Article Type] Article
Antigen Specific Humoral and Cellular Immunity Following SARS-CoV-2 Vaccination in ANCA-Associated Vasculitis Patients Receiving B-Cell Depleting TherapyB 세포 고갈 요법을 받는 ANCA 관련 혈관염 환자에서 SARS-CoV-2 백신 접종 후 항원 특이적 체액 및 세포 면역Immunology Published on 2022-01-282022-09-11 Journal: Frontiers in Immunology [Category] 진단, 치료법, [키워드] ANCA-associated vasculitis anti-CD20 anti-CD20 therapy anti-SARS-CoV-2 Anti-spike antibody assays B-cell B-cells cellular Cellular immune response characterized control subjects controls COVID-19 vaccination elicit ELISPOT enzyme-linked immunosorbent humoral humoral immune response Humoral response immune responses immunoassays interferon lack mounted Patient patients peptide peptide pool positive Protective protective effect receiving Receptor binding domain recovered patient Research response rituximab robust S glycoprotein SARS-CoV-2 SARS-CoV-2 vaccination Specific Specific T-cell response subject subjects subunit T-cell immunity T-cell Response T-cell responses targeted therapy vaccination Vaccine vaccine response Vasculitis were measured [DOI] 10.3389/fimmu.2022.834981 PMC 바로가기 [Article Type] Immunology
Promising Assays for Examining a Putative Role of Ribosomal Heterogeneity in COVID-19 Susceptibility and SeverityReview Published on 2022-01-282022-10-29 Journal: International Review of Cell and Molecular Biology [Category] COVID-19, [키워드] analyses Antiviral treatment arise assays for proteins assays for RNA sequence and structure caused Characteristics characterized clinical sample clinical setting component concurrent COVID-19 COVID-19 disease Critical detect droplet Efficacy element environmental cues Examining generate heterogeneity Host host susceptibility identify include Infection Messenger RNA modifications mRNA Nanopore organism post-translational modification protocol responses ribosomal heterogeneity ribosomal protein ribosomal proteins ribosomal RNA ribosomal RNAs ribosome ribosomes RNA genome RNA sequencing role rRNA rRNAs SARS-CoV-2 SARS-CoV-2 coronavirus selected sequence Sequencing severity of symptoms Side effect Single Cell Statistical power structural variations structures substrate Symptoms the disease the SARS-CoV-2 transcript translate translation translation machinery translational Transmissibility unique vaccine immunogenicity vaccine response variant viral infectivity [DOI] 10.3390/life12020203 PMC 바로가기 [Article Type] Review
Interleukin-1 Inhibitors and Vaccination Including COVID-19 in Inflammatory Rheumatic Diseases: A Nonsystematic Review염증성 류마티스 질환에서 코로나19를 포함한 인터루킨-1 억제제 및 백신 접종: 비체계적 검토Review Published on 2022-01-272022-09-11 Journal: Frontiers in Immunology [Category] 변종, 진단, [키워드] accumulating addressed anti-cytokine anti-cytokine therapy autoimmune/autoinflammatory rheumatic diseases baseline blockade blockers blocking agent blocking agents canakinumab coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 Course COVID-19 COVID-19 disease COVID-19 in patient COVID-19 vaccination develop disease Disease activity drug level drug levels Efficacy and safety half-live hand healthy help IL-1 Immunosuppression Including interleukin interleukin-1 interleukin-1 inhibitors medical emergency moderate novel vaccines Patient Prognosis raise returned review rheumatic disease Rheumatic diseases rilonacept rising risk SARS-CoV-2 selected Seven severe COVID-19 disease Spread the disease the timing vaccination Vaccine vaccine response variant [DOI] 10.3389/fimmu.2021.734279 PMC 바로가기 [Article Type] Review
Protocol for SARS-CoV-2 post-vaccine surveillance study in Australian adults and children with cancer: an observational study of safety and serological and immunological response to SARS-CoV-2 vaccination (SerOzNET)SARS-COV-2 호주 성인 및 암 소아에서의 산후 감시 연구 프로토콜 : SARS-COV-2 백신 접종 (Seroznet)에 대한 안전 및 혈청 학적 및 면역 학적 반응에 대한 관찰 연구 (Seroznet)Study Protocol Published on 2022-01-202022-09-10 Journal: BMC Infectious Diseases [Category] SARS, 변종, 임상, [키워드] acceptability adverse event adverse events allergy Analysis Blood Cancer Cancer patients Characteristics Chemotherapy children clinical clinical trial clinical trials cohorts collected commenced comparable condition controls coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 infection COVID-19 vaccinations COVID-19 vaccine COVID-19 vaccines disease manifestation effective enrolled exploration FIVE haematological malignancy healthy healthy control healthy controls HM patient HM patients hypogammaglobulinaemia Immune checkpoint inhibitor Immune checkpoint inhibitors immune correlate immune correlates immune response Immunity Immunocompromise Immunological response Immunosuppression immunosuppressive condition immunosuppressive conditions incidence Infection less life malignancy morbidity and mortality naïve New observational study organ pandemic coronavirus Patient Patients with cancer peripheral Peripheral blood Polysorbate polysorbate 80 populations Post-vaccine pre-vaccination processed proportion prospective observational study Quality question receiving reducing Registered Registration registry reported required robust SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 vaccine Serologic response serologic responses serological serological response severe COVID-19 SOC solid organ supplementary material Surveillance systemic therapy T-cell therapy timepoint Toxicity Treatment Trial unique vaccination Vaccinations Vaccine Vaccine hesitancy vaccine response variants virus were excluded [DOI] 10.1186/s12879-021-07019-1 PMC 바로가기 [Article Type] Study Protocol
Development and utilization of a surrogate SARS-CoV-2 viral neutralization assay to assess mRNA vaccine responsesmRNA 백신 반응을 평가하기 위한 대리 SARS-CoV-2 바이러스 중화 분석의 개발 및 활용Research Article Published on 2022-01-182022-09-12 Journal: PLoS ONE [Category] 진단, [키워드] angiotensin angiotensin converting enzyme biosafety biotinylated booster Booster vaccine Complete configuration correlation COVID COVID-19 COVID-19 patient COVID-19 patients Decline declines development doses ELISA ELISAs enzyme evaluate gold gold standard help heterogeneous highlight Highlights host receptor immunoassay Infection inhibitory activity Interaction Longitudinal analyses longitudinal analysis mRNA vaccine Neutralization assay neutralization test Neutralizing activity plaque reduction neutralization Plaque reduction neutralization test post vaccination PRNT raise RBD receptor Receptor binding domain recipient Recovered COVID-19 patients response SARS-CoV-2 immunity SARS-CoV-2 spike SARS-CoV-2 viral serum Serum neutralizing antibody significant difference significant differences significantly higher Spike protein Test tested vaccinated individual vaccination Vaccine vaccine response vaccine responses viral culture was used within 6 months [DOI] 10.1371/journal.pone.0262657 PMC 바로가기 [Article Type] Research Article
Persistent T-Cell Reactivity in a Seronegative Patient after SARS-CoV-2 Infection and One VaccinationCase Report Published on 2022-01-132022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] antibodies antibody Antibody detection Antibody Response AstraZeneca Cambridge Case report cell immunity ChAdOx1 CoNAN COVID-19 detectable develop IFNγ Infection limitation male mild SARS-CoV-2 infection Neustadt am Rennsteig patients PCR-confirmed persistent produced remained robust SARS-CoV-2 serological test T cell responses T immunity T-cell immunity Th cell TNF vaccination vaccine response [DOI] 10.3390/vaccines10010114 PMC 바로가기 [Article Type] Case Report
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysisSARS-CoV-2 변이체에 대한 보호 예측 인자로서의 중화 항체 역가 및 부스팅의 영향: 메타 분석Meta-Analysis Published on 2022-01-012022-09-11 Journal: The Lancet. Microbe [Category] MERS, SARS, 변종, 진단, [키워드] Alpha analysed Analysis Antibody titre Beta booster vaccination correlated decrease decreases Effect Efficacy elicited Future In-vitro infected individual Infection infection with SARS-CoV-2 Medical Research Council medium Meta-analysis neutralisation neutralisation titre Neutralising activity not significantly different outcome predict predicted Predictive predictor reduced remained robust SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants serum Severe infection shown statistical model suggested symptomatic infection titre vaccination vaccination schedule Vaccine vaccine efficacy vaccine response vaccine responses Vaccines variant variants variants of concern virus virus infection waning immunity [DOI] 10.1016/S2666-5247(21)00267-6 PMC 바로가기 [Article Type] Meta-Analysis
Gut microbiome, Vitamin D, ACE2 interactions are critical factors in immune-senescence and inflammaging: key for vaccine response and severity of COVID-19 infection장내 미생물군유전체, 비타민 D, ACE2 상호작용은 면역노화 및 염증의 중요한 요소입니다: 백신 반응 및 COVID-19 감염의 중증도에 대한 핵심Review Published on 2022-01-012022-09-11 Journal: Inflammation research : official journal of the Eu [Category] SARS, 유전자 메커니즘, [키워드] ACE-2 ACE2 Adaptive immune response addition affected article assist association Blood Clinical outcome clinical outcomes Combination complex correlation COVID-19 COVID-19 infections COVID-19 sepsis COVID-19 severity Critical cross-talk determine Diseases Evidence expression Factor function growth Gut gut microbiome gut microbiota host response host responses immune responses immune system immune-senescence immunomodulatory include indicate Infection inflammaging Inflammation Inflammatory marker inflammatory markers interact Interaction microbial Microbiome molecular Mortality outcome Predictive promote Regulation Renin Research SARS-COV-2 infection SARS-CoV-2 pandemic Sepsis severity severity of COVID-19 Signaling Spread state status strain Systems biology vaccination Vaccine vaccine response vaccine responses viral infection Vitamin D with COVID-19 [DOI] 10.1007/s00011-021-01510-w PMC 바로가기 [Article Type] Review
COVID-19 Vaccine Response in People with Multiple Sclerosis다발성 경화증 환자의 코로나19 백신 반응Article Published on 2022-01-012022-09-12 Journal: Annals of neurology [Category] MERS, SARS, 진단, [키워드] 95% CI 95% confidence interval age ANN anti-CD20 anti-CD20 treatment anti-SARS-CoV-2 antibody Blood calculated cellular Cohort coronavirus disease COVID-19 disease drug drug history immune response Logistic regression Lymphocyte count management medical records medications monoclonal antibody Multiple multiple sclerosis not differ Odds ratio Patient predicted provided Quantitative questionnaire recommendation regression modeling response risk SARS-CoV-2 SARS-CoV-2 vaccination sclerosis Seroconversion serological response seronegative significantly subject T cell responses T-cell immunity tested the SARS-CoV-2 therapy Treatment vaccination Vaccine vaccine response [DOI] 10.1002/ana.26251 PMC 바로가기 [Article Type] Article